Durability of SARS-CoV-2 Antibodies from Natural Infection in Children and Adolescents

The authors have withdrawn this manuscript for the following reasons: O_LIOur latest analysis (mid-February, 2022) that includes the addition of 59 children with 3 completed timepoints shows a decrease in N antibodies at T2, versus this preprint that showed an increase in N antibodies from T1 to T2. C_LIO_LIThis preprint did not include those infected with the Omicron variant, which has had a substantial impact on the increase in pediatric infections and has important implications for antibody durability moving forward as such. C_LI Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.